Free Trial

Dermata Therapeutics (DRMAW) SEC Filings & 10K Form

$0.02 +0.00 (+3.14%)
As of 08/15/2025 09:46 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Dermata Therapeutics SEC Filings

DateFilerForm TypeView
08/14/2025
8:08 PM
ARMISTICE CAPITAL, LLC (Filed by)
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
Form SCHEDULE 13G
07/30/2025
8:00 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2025
4:25 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2025
8:00 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2025
4:20 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
2:26 PM
ARMISTICE CAPITAL, LLC (Filed by)
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
Form SCHEDULE 13G/A
05/14/2025
8:00 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2025
8:01 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
11:15 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form EFFECT
04/15/2025
7:30 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2025
8:37 PM
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
PROEHL GERALD T (Filed by)
Form SCHEDULE 13D/A
04/03/2025
5:00 PM
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
PROEHL GERALD T (Filed by)
Form SCHEDULE 13D/A
03/28/2025
4:01 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
7:00 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
4:29 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
3:15 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/17/2025
3:17 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:41 PM
ARMISTICE CAPITAL, LLC (Filed by)
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
Form SCHEDULE 13G/A
02/13/2025
5:00 PM
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
PROEHL GERALD T (Filed by)
Form SCHEDULE 13D/A
02/05/2025
11:15 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form EFFECT
02/05/2025
4:30 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 424B3
02/04/2025
3:22 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form D/A
01/30/2025
3:09 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/28/2025
4:25 PM
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SCHEDULE 13G
01/28/2025
4:00 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/23/2025
8:54 PM
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
PROEHL GERALD T (Filed by)
Form SCHEDULE 13D/A
01/23/2025
4:00 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
HALE DAVID F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:02 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
PROEHL GERALD T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:03 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Van Hoose Kyri K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:04 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
FISHER MARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:16 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
7:05 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
5:56 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
WIERENGA WENDELL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:56 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
HALE DAVID F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:56 PM
Bedoya-Toro Munera Maria E (Reporting)
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:57 PM
Bradrick Brittany (Reporting)
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:57 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Nardo Christopher J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:58 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Sandler Andrew Seth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:49 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:50 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Mento Steven J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:50 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
PROEHL GERALD T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)

The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.

See his full breakdown of the seven stocks to own now
01/14/2025
5:50 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Van Hoose Kyri K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:50 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
FISHER MARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:16 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/27/2024
4:00 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
09/24/2024
11:15 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form EFFECT
09/24/2024
3:16 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 424B3
09/19/2024
3:46 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/17/2024
4:25 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DRMAW) was last updated on 8/17/2025 by MarketBeat.com Staff
From Our Partners